Frazier Life Sciences
Startup rounds since 2012 with a Frazier Life Sciences investor on the board, and the firm's own fund filings.
Raises
67
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
5
fund filings under the firm's name
Rounds
- Enlaza Therapeutics, Inc.$15M
- Enlaza Therapeutics, Inc.$84M
- Sudo Biosciences, Inc.$63.6M
- Enlaza Therapeutics, Inc.$35.3M
- MBX Biosciences, Inc.$46.7M
- Enlaza Therapeutics, Inc.Undisclosed
- Enlaza Therapeutics, Inc.Undisclosed
- 98point6 Inc.$20.9M
- Sudo Biosciences, Inc.$22.2M
- Scout Bio, Inc.$4.75M
- Alpine Immune Sciences, Inc.$91M
- Enlaza Therapeutics, Inc.Undisclosed
- Enlaza Therapeutics, Inc.Undisclosed
- Amunix Pharmaceuticals, Inc.$117M
- Seraxis Holdings, Inc.$14M
- Amunix Pharmaceuticals, Inc.Undisclosed
- Imago BioSciences, Inc.$80M
- 98point6 Inc.$119M
- Alpine Immune Sciences, Inc.$60M
- Amunix Pharmaceuticals, Inc.Undisclosed
- 98point6 Inc.$37.2M
- SutroVax, Inc.$110M
- Amunix Pharmaceuticals, Inc.$83.6M
- Arcutis Biotherapeutics, Inc.$94.5M
- Scout Bio, Inc.$20M
- Imago BioSciences, Inc.$17M
- Alpine Immune Sciences, Inc.$25.3M
- Mirum Pharmaceuticals, Inc.$60.1M
- 98point6 Inc.$50M
- Recida Therapeutics, Inc.$5.67M
- SutroVax, Inc.$43.2M
- Aptinyx Inc.$70M
- Center for Orthopedic & Research Excellence, Inc.$2.2M
- Alcresta Therapeutics, Inc.$10M
- Cirius Therapeutics, Inc.$30M
- Ebh Holding Company, Inc.$39.3M
- SutroVax, Inc.$40.1M
- Imago BioSciences, Inc.$40.5M
- Center for Orthopedic & Research Excellence, Inc.$14M
- Alcresta Therapeutics, Inc.$50.9M
- Silvergate Pharmaceuticals, Inc.$4.6M
- PowerVision, Inc.$45.1M
- Alpine Immune Sciences, Inc.$10.3M
- Aptinyx Inc.$25M
- Merganser Biotech, Inc.$13.1M
- Zavante Therapeutics, Inc.$45.7M
- Atterocor, Inc.$47.7M
- Allena Pharmaceuticals, Inc.$51.4M
- Ebh Holding Company, Inc.$12.5M
- Silvergate Pharmaceuticals, Inc.$1.6M
- Ebh Holding Company, Inc.$2M
- Ebh Holding Company, Inc.$3M
- Laguna Pharmaceuticals, Inc.$4.48M
- Anaptysbio Inc$40.8M
- Nexcida Therapeutics, Inc.$2.75M
- Ebh Holding Company, Inc.$4M
- Cidara Therapeutics, Inc.$42M
- ChanRx Corp.$16.6M
- Allena Pharmaceuticals, Inc.$25M
- VentiRx Pharmaceuticals Inc.$15M
- VentiRx Pharmaceuticals Inc.$50.6M
- Silvergate Pharmaceuticals, Inc.$1M
- K2 Therapeutics, Inc.$30.3M
- K2 Therapeutics, Inc.$6M
- ProNAi Therapeutics Inc$59.5M
- Cardiac Dimensions Inc$1.2M
- Collegium Pharmaceutical Inc$22.5M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 1 | 0 |
| 2024 | 2 | — |
| 2022 | 6 | — |
| 2021 | 7 | — |
| 2020 | 7 | — |
| 2019 | 4 | — |
| 2018 | 4 | — |
| 2017 | 7 | — |
| 2016 | 9 | — |
| 2015 | 11 | — |
| 2014 | 8 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Frazier Life Sciences XII, L.P. | 17 Mar 2025 | Open-ended | — |
| Frazier Life Sciences XI, L.P. | 18 Mar 2022 | $960M | $960M |
| Frazier Life Sciences X, L.P. | 17 Dec 2019 | $617M | — |
| Frazier Life Sciences IX, L.P. | 1 Nov 2017 | $419M | $419M |
| Frazier Life Sciences VIII, L.P. | 29 Oct 2015 | $262M | $262M |
Listed because a Frazier Life Sciences fund's filing names a director of each company. A name match is not a verified identity.